Omega7

Omega 7, Inc. was a biotechnology company focused on the research and development of palmitoleic acid, a specific omega-7 fatty acid, for the management of metabolic and cardiovascular health. The company pioneered the use of purified palmitoleic acid to reduce systemic inflammation, improve lipid profiles, and enhance insulin sensitivity. Its lead product, Provinal, was developed as a highly concentrated omega-7 supplement designed to lower C-reactive protein levels and address components of metabolic syndrome. In 2012, the company was acquired by Tersus Life Sciences, which continues to commercialize and expand the applications of its omega-7 technology. Omega 7's work significantly contributed to the scientific understanding of monounsaturated fatty acids as signaling molecules in human metabolism.